CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions

By afschroeder • December 23, 2025

Patil T, Lin JJ, Cheema PK, Carrizosa DR, Burkard ME, Elamin YY, Desai J, Patel JD, Nagasaka M, Reckamp KL, Waqar SN, Bauman JR, Schram AM, Gadgeel SM, Ma PC, Konduri K, Nguyen D, Misleh J, Bleeker J, Weiss M, Thavaneswaran S, Haura EB, Deegan M, Kaufman J, Srivastava J, Jansen VM, Liu SV. CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions. JCO Precis Oncol. 2025 Aug;9:e2500221. doi: 10.1200/PO-25-00221. Epub 2025 Dec 22. PMID: 41428976.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

On Mentoring

Weisman MH. On Mentoring. Arthritis Care Res (Hoboken). 2026 Mar 23. doi: 10.1002/acr.80045. Epub ahead of print. PMID: 41869975.

The Impact of Transitioning to Virtual Fall-Prevention Programs on Falls and Social Connectedness in Community-Dwelling Older Adults

Mays AM, Au T, Kim S, Guevara N, Rosen SL. The Impact of Transitioning to Virtual Fall-Prevention Programs on Falls and Social Connectedness in Community-Dwelling[...]

The Safety Action Feedback and Engagement (SAFE) Loop: Initial Testing and Refinement of a Novel Intervention to Enhance Hospital Incident Reporting and Patient Safety

Seferian E, Berdahl CT, Coleman B, Leang D, Cohen T, Qureshi N, McCleskey SG, Kaiser K, Grissinger M, Kanji F, Henreid AJ, Carrascoza-Bolanos J, Daniels[...]